Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography

dc.contributor.authorSantos, Everaldo Silvino dos
dc.contributor.authorSousa Junior, Francisco Canindé de
dc.contributor.authorVaz, Michelle Rossana Ferreira
dc.contributor.authorPadilha, Carlos Eduardo de Araújo
dc.contributor.authorMartins, Daniella Regina Arantes
dc.contributor.authorMacedo, Gorete Ribeiro de
dc.date.accessioned2021-05-21T01:52:31Z
dc.date.available2021-05-21T01:52:31Z
dc.date.issued2014-10-01
dc.description.resumoVisceral leishmaniasis, a disease caused by Leishmania infantum chagasi, represents a major public health problem in many areas of the world. Despite the considerable effort, there is no effective and safe vaccine for human use [1]. Some authors have reported that as much as 50% of overall costs in the biotechnology industries are related to downstream processing. Thus, the development of new and economically advantageous purification methods is a challenge [2]. Expanded bed adsorption (EBA) is an innovative chromatography technology that allows the adsorption of target proteins directly from unclarified feedstock. EBA technology combines solid-liquid separation with an adsorption step in a single-unit operation, aiming at increased overall yield, reduced operational time, and less capital investment and consumables [3,4]. Thus, the aim of this work was to purify the 503 antigen of Leishmania i. chagasi directly from crude feedstock using EBA chromatographypt_BR
dc.identifier.citationSOUSA JUNIOR, Francisco Canindé de; VAZ, Michelle Rossana Ferreira; PADILHA, Carlos Eduardo de Araújo; MARTINS, Daniella Regina Arantes; MACEDO, Gorete Ribeiro de; SANTOS, Everaldo Silvino dos. Production, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatography. Bmc Proceedings, [S.L.], v. 8, n. 4, out. 2014. Disponível em: https://bmcproc.biomedcentral.com/articles/10.1186/1753-6561-8-S4-P194. Acesso em: 08 abr. 2021. https://doi.org/10.1186/1753-6561-8-S4-P194pt_BR
dc.identifier.doi10.1186/1753-6561-8-S4-P194
dc.identifier.issn1753-6561
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/32543
dc.languageenpt_BR
dc.publisherBMCpt_BR
dc.rightsAttribution 3.0 Brazil*
dc.rightsAttribution 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.subjectVisceral Leishmaniasispt_BR
dc.subjectLeishmaniasispt_BR
dc.subjectElution Conditionpt_BR
dc.subjectBatch Adsorption Experimentpt_BR
dc.subjectLeishmania Infantumpt_BR
dc.titleProduction, recovery, and purification of recombinant 503 antigen of Leishmania infantum chagasi using expanded bed adsorption chromatographypt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
ProductionRecoveryPurification_Santos_2014.pdf
Tamanho:
251.72 KB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar